CASI Pharmaceuticals
CASI
#10178
Rank
NZ$32.47 M
Marketcap
NZ$1.58
Share price
9.02%
Change (1 day)
-73.27%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -NZ$74.17 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$31.56 Million. In 2024 the company made an earning of -NZ$65.43 Million a decrease over its 2023 earnings that were of -NZ$45.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$74.17 Million13.36%
2024 -NZ$65.43 Million44.35%
2023 -NZ$45.33 Million-29.55%
2022 -NZ$64.33 Million4.43%
2021 -NZ$61.6 Million-24.56%
2020 -NZ$81.65 Million4.74%
2019 -NZ$77.96 Million65.13%
2018 -NZ$47.21 Million155.07%
2017 -NZ$18.51 Million13.93%
2016 -NZ$16.25 Million31.18%
2015 -NZ$12.39 Million-72.5%
2014 -NZ$45.03 Million356.62%
2013 -NZ$9.87 Million-60.55%
2012 -NZ$25 Million218.41%
2011 -NZ$7.86 Million0.74%
2010 -NZ$7.8 Million-32.54%
2009 -NZ$11.56 Million-66.98%
2008 -NZ$34.99 Million-14.22%
2007 -NZ$40.79 Million7.04%
2006 -NZ$38.1 Million27.95%
2005 -NZ$29.78 Million4.51%
2004 -NZ$28.5 Million-15.84%
2003 -NZ$33.86 Million-55.29%
2002 -NZ$75.73 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$87.16 Million31.56%
1999 -NZ$66.26 Million145.56%
1998 -NZ$26.99 Million76.4%
1997 -NZ$15.3 Million36.92%
1996 -NZ$11.18 Million